Andrew Fisher Verona Pharma PLC (VRNA) insider trading activity
Andrew Fisher is General Counsel of Verona Pharma plc. Currently has a direct ownership of 300,000 shares of VRNA, which is worth approximately $11.4 Million. The most recent transaction as insider was on Oct 30, 2024, when has been sold 300,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
300K
n/a
3M change
n/a
12M change
Total Value Held
$11.4 Million
AF
Andrew Fisher
General Counsel
London, X0